BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6482668)

  • 1. Discriminative stimulus properties of the serotonin agonist 1-(3-trifluoromethylphenyl)piperazine (TFMPP).
    Glennon RA; McKenney JD; Young R
    Life Sci; 1984 Oct; 35(14):1475-80. PubMed ID: 6482668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discriminative stimulus effects of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane (DOM), ketanserin, and (R)-(+)-{alpha}-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-pipidinemethanol (MDL100907) in rats.
    Li JX; Unzeitig A; Javors MA; Rice KC; Koek W; France CP
    J Pharmacol Exp Ther; 2009 Nov; 331(2):671-9. PubMed ID: 19687292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antagonism of the effects of the hallucinogen DOM and the purported 5-HT agonist quipazine by 5-HT2 antagonists.
    Glennon RA; Young R; Rosecrans JA
    Eur J Pharmacol; 1983 Jul; 91(2-3):189-96. PubMed ID: 6617740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discriminative stimulus properties of the 5-HT1A agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH DPAT).
    Glennon RA
    Pharmacol Biochem Behav; 1986 Jul; 25(1):135-9. PubMed ID: 2944129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible 5-hydroxytryptamine1 (5-HT1) receptor involvement in the stimulus properties of 1-(m-trifluoromethylphenyl)piperazine (TFMPP).
    Cunningham KA; Appel JB
    J Pharmacol Exp Ther; 1986 May; 237(2):369-77. PubMed ID: 2939233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discriminative stimulus properties of the serotonergic agent 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI).
    Glennon RA
    Life Sci; 1986 Sep; 39(9):825-30. PubMed ID: 2943960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-HT1 and 5-HT2 binding characteristics of some quipazine analogues.
    Glennon RA; Slusher RM; Lyon RA; Titeler M; McKenney JD
    J Med Chem; 1986 Nov; 29(11):2375-80. PubMed ID: 3783595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discriminative stimulus effects of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane in rhesus monkeys: antagonism and apparent pA2 analyses.
    Li JX; Rice KC; France CP
    J Pharmacol Exp Ther; 2009 Mar; 328(3):976-81. PubMed ID: 19098164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TFMPP may produce its stimulus effects via a 5-HT1B mechanism.
    McKenney JD; Glennon RA
    Pharmacol Biochem Behav; 1986 Jan; 24(1):43-7. PubMed ID: 3945665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discriminative stimulus effects of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane in rhesus monkeys.
    Li JX; Rice KC; France CP
    J Pharmacol Exp Ther; 2008 Feb; 324(2):827-33. PubMed ID: 17993605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of serotonin 5-HT1A receptor agonists on the discriminative stimulus effects of the 5-HT2A receptor agonist 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane in rats and rhesus monkeys.
    Li JX; Koek W; Rice KC; France CP
    J Pharmacol Exp Ther; 2010 Apr; 333(1):244-52. PubMed ID: 20053932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discriminative stimulus properties of (+/-)-fenfluramine: the role of 5-HT2 receptor subtypes.
    McCreary AC; Filip M; Cunningham KA
    Behav Neurosci; 2003 Apr; 117(2):212-21. PubMed ID: 12708517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discriminative stimulus properties of the serotonin agonist MK 212.
    Cunningham KA; Callahan PM; Appel JB
    Psychopharmacology (Berl); 1986; 90(2):193-7. PubMed ID: 3097699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discriminative stimulus properties of 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane [(+/-)DOI] in C57BL/6J mice.
    Smith RL; Barrett RJ; Sanders-Bush E
    Psychopharmacology (Berl); 2003 Feb; 166(1):61-8. PubMed ID: 12474110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of TFMPP stimulus properties as a model of 5-HT1B receptor activation.
    Schechter MD
    Pharmacol Biochem Behav; 1988 Sep; 31(1):53-7. PubMed ID: 3252260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of 5-HT receptor subtypes in the discriminative stimulus properties of mescaline.
    Appel JB; Callahan PM
    Eur J Pharmacol; 1989 Jan; 159(1):41-6. PubMed ID: 2707301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of 5-HT2C receptors in mediating the discriminative stimulus properties of m-chlorophenylpiperazine (mCPP).
    Callahan PM; Cunningham KA
    Eur J Pharmacol; 1994 May; 257(1-2):27-38. PubMed ID: 8082704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanistic studies on DOM as a discriminative stimulus.
    Glennon RA; Hauck AE
    Pharmacol Biochem Behav; 1985 Dec; 23(6):937-41. PubMed ID: 2934750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discriminative stimulus properties of DOM and several molecular modifications.
    Glennon RA; Young R; Rosecrans JA
    Pharmacol Biochem Behav; 1982 Apr; 16(4):553-6. PubMed ID: 7071088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioral and serotonin receptor properties of 4-substituted derivatives of the hallucinogen 1-(2,5-dimethoxyphenyl)-2-aminopropane.
    Glennon RA; Young R; Benington F; Morin RD
    J Med Chem; 1982 Oct; 25(10):1163-8. PubMed ID: 7143352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.